Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideTMOThermo Fisher Scientific
FinDog View：Neutral
| Metric | MRNA | TMO |
|---|
| Close | 221.72 | 697.00 |
| Market Cap | $88.3B | $258B |
| 1M | +15.14% | +3.25% |
| P/E (TTM) | — | 36.4 |
| Forward P/E | — | 24.6 |
| P/E 5-Yr Percentile | — | 78 |
| P/S | 39.7 | 5.4 |
| P/B | 13.1 | 4.7 |
| Dividend Yield | — | 0.29% |
| Latest Quarter Revenue | $145M | $12.1B |
| Revenue YoY | +2.1% | +9.1% |
| Gross Margin | 35.9% | — |
| Latest Quarter EPS | -1.97 | 4.64 |
| Avg Post-Earnings Move | ±4.2% | ±1.2% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | — | 1.82% |
| 90-Day Net Insider Buying | −$62.6M | −$40.3M |
MRNA · Revenue, Last 8 Quarters ($B)
TMO · Revenue, Last 8 Quarters ($B)
